British Columbia first province to switch patients to biosimilars
British Columbia has said it will switch as many as 20,400 patients from three branded biologic drugs to cheap biosimilars.
List view / Grid view
News
CPhI China opens with analysis pointing to a surge in growth in 2019
Regulatory reforms and harmonisation reported as key drivers of industry in China.
BPOG extractables testing of AdvantaPure®’s key silicone and TPE tubing products complete
Test results help drug manufacturers compare tubing.
FDA approves first gene therapy for paediatric spinal muscular atrophy
The FDA has given approval to AveXis for the first treatment of paediatric spinal muscular atrophy (SMA).
$85 million settlement agreed for opioid case in Oklahoma
Teva has agreed to pay Oklahoma, resolving allegations that illegal marketing of its medication contributed to the state’s opioid epidemic.
First PI3K inhibitor for breast cancer approved by FDA
The US Food and Drug Administration (FDA) has approved Piqray (alpelisib) tablets to treat patients with breast cancer.
LABVOLUTION: Paving the way for the lab of the future
The connected laboratory is now the only way forward, as the three days of the LABVOLUTION show have clearly demonstrated. Decision-makers, product developers and users from the various segments of the laboratory industry gathered in Hannover for a close look at the latest developments and future trends.
Retail prices on several anti-cancer medications slashed
The retail prices of some anti-cancer drugs have been cut by 87 percent by the drug price control authority in India.
FDA sends warning letter to Canadian OTC manufacturer
FDA sends warning to Petra Hygienic Systems Int LTD after they find violations of current good manufacturing practices (cGMPs).
Patent litigation for adalimumab resolved in the US
AbbVie has announced that it has resolved its US HUMIRA (adalimumab) litigation with Boehringer Ingelheim.
Four drug companies accused of illegal market sharing
The CMA accuses four pharmaceutical firms of colluding to illegally inflate prices of an anti-nausea drug.
Mirikizimab moved to Phase III after positive trial findings
Eli Lilly presents new data for their mirikizimab treatment for Crohn’s disease.
Single vaccination approach developed to combat respiratory diseases
Scientists have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections.
Pharmaceutical cleanroom monitoring software solution
Particle Measuring Systems releases the new Pharmaceutical Net® Pro Environmental Monitoring Software for FacilityPro® Environmental Monitoring Systems.
Platform launched to facilitate licensed import of medical cannabis in EU
The first platform to facilitate the licensed importation of medical cannabis into Europe has formally launched in the UK.
